RoboScore
45.7
Out of 100. Its robots, plus proof from customers and the press.
All 6 measures have data
News bonus
0.8
From the last 90 days, up to 15
RoboIndex
46.5
Down 0.2 since the 19 Oct ranking
Rank change
No change
Now #30 of 39 in Surgical / Medical · See the board →
Teleoperated endovascular robotics
Is this your company? Claim it, free. Fix your record, add videos, see who looks.
Claim SentanteMoney and customers
Raised
US$6.6M
Last raise · Seed · Dec 2023
Customers
None
No named customer yet
What the score is made of
How it worksThe score is 65% robots, 30% proof from customers and the press, 5% range of robots. Activity and readiness are shown for context.
Backed by
FUNDING ROUNDS AND CUSTOMERS BY ROBOT
Bigger dot = bigger round. Hollow = amount not disclosed.
Funding rounds
- Dec 2023SeedUS$6.6MLed by Practica Capital3 outlets ↗
Rounds recorded from January 2017. Every amount links to its source.
Suggest an editCustomers
No deployment evidence on file
A deployment is recorded when a public source names both the customer and the robot, or the maker confirms it. Nothing here counts against Sentante.
In Surgical / Medical, CMR Surgical, BD Rowa and Catalia Health have deployment evidence on file.
Add a deployment →Sentante is a Vilnius, Lithuania medical-robotics company, founded in 2017, developing a haptic teleoperated endovascular robotic platform for remote vascular procedures. Its system received a CE mark in 2026.
Active products
1
Company facts
- HQ
- Vilnius, LT
- Founded
- 2017 · 9 yrs
- Stage
- Seed
- Website
- sentante.com
Active robots by Sentante
1 shown| # | Category | ||||
|---|---|---|---|---|---|
| 1 | Sentante Endovascular Robotic System | Surgical / Medical | 2026 | 41.8 |
In the news
1 event · last 90 days
+0.8news bonus- Aug 25Sentante’s Endovascular Robot Enters Commercial Use in Vascular Surgery
In the news
1 event · last 90 days
Why Sentante has been in the news, across 1 outlet, collected and classified independently, so a maker cannot add to it. It never changes a robot's RoboScore (the evidence half of the RoboIndex) and it can move a robot up a board by at most 15 points.
Safety reports
Consumer product alerts from this country reach the EU Safety Gate, which we read. Industrial, workplace and medical incidents never enter it, so a blank record says nothing about those.
Surgical / Medical buying guides
Industry Knowledge →
Surgical Robot Vendor Selection: Support Coverage, Software Upgrades, and Lifecycle
A surgical robot purchased today will be in your OR for 10–15 years. The support SLA, software upgrade path, end-of-life timeline, and field service model deter…
Pilot to Scale: Case Volume Thresholds for Surgical Robot ROI
Most surgical robot programs break even somewhere between 150 and 400 cases per year depending on platform, procedure mix, and reimbursement. The math is knowab…
Surgeon Training Curve and Proctoring: The 18-Month Onboarding Window
A surgeon's robotic learning curve runs 20–150 cases depending on procedure and prior experience. The proctoring structure, credentialing ladder, and OR efficie…
People also compare
- Xact Robotics47.0RoboIndexCompare Sentante vs Xact Robotics
- Rex Bionics46.0RoboIndexCompare Sentante vs Rex Bionics
- Veebot Systems47.5RoboIndexCompare Sentante vs Veebot Systems